Lassa Fever Crisis Deepens: Nigeria Reports 191 Deaths as Delayed Treatment Fuels Outbreak

Nigeria is grappling with a worsening Lassa fever outbreak, as the Nigeria Centre for Disease Control and Prevention (NCDC) reports a staggering 191 deaths—a sharp increase from previous years. The current case fatality rate (CFR) stands at 37.2%, nearly double the 19.2% recorded during the same period in 2025, signaling a critical deterioration in outbreak management.

Why This Is Escalating

• Delayed Treatment: Many patients seek medical care only after symptoms become severe, reducing survival chances. Lassa fever’s early signs—fever, fatigue, and muscle pain—are often mistaken for malaria or typhoid, leading to misdiagnosis.
• Healthcare Gaps: Limited access to diagnostic tools in rural areas delays confirmation of cases, while overwhelmed treatment centers struggle with resource shortages, including ribavirin, the primary antiviral drug.
• Rodent Control Failures: The multimammate rat, the virus’s primary reservoir, thrives in unsanitary conditions. Poor waste management and food storage practices in endemic regions continue to facilitate transmission.

Understanding the Condition

Lassa fever is an acute viral hemorrhagic illness caused by the Lassa virus, a member of the Arenaviridae family. Transmission occurs through:

• Direct contact with infected rodents or their excreta.
• Consumption of contaminated food or water.
• Human-to-human spread via bodily fluids, particularly in healthcare settings.

Symptoms typically appear 6–21 days post-exposure and include:

• High fever and severe weakness.
• Unexplained bleeding from orifices (e.g., gums, nose).
• Gastrointestinal distress (vomiting, diarrhea).
• Neurological complications in advanced stages.

Without early intervention, the disease progresses rapidly, with mortality rates reaching 50% in hospitalized cases.

NCDC’s Response and Challenges

The NCDC has intensified surveillance and contact tracing, deploying rapid response teams to high-burden states like Edo, Ondo, and Bauchi. However, persistent challenges include:

• Diagnostic Bottlenecks: Only a handful of laboratories nationwide can test for Lassa fever, creating backlogs and delaying results.
• Public Awareness: Misconceptions about the disease persist, with many attributing symptoms to supernatural causes rather than seeking medical care.
• Funding Constraints: Under-resourced state health systems struggle to sustain outbreak responses, relying heavily on federal support and international partners.

MedSense Insight

This outbreak underscores the fragility of Nigeria’s infectious disease infrastructure. The spike in fatalities reflects systemic issues—from diagnostic delays to community-level misinformation—that demand urgent, multi-sectoral solutions. Strengthening primary healthcare, expanding laboratory capacity, and investing in rodent control programs are critical to curbing future outbreaks.

Key Takeaway

• Lassa fever’s 37.2% CFR in 2026 is nearly double the 2025 rate, highlighting the deadly consequences of delayed treatment.
• Rodent control and public education remain pivotal in breaking transmission chains, yet implementation gaps persist.
• Nigeria’s outbreak response requires sustained funding, decentralized diagnostics, and stronger healthcare worker training to prevent further escalation.